Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015
VIKASLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vikas Lifecare has disclosed that an arbitration it had filed against Eraaya Lifespaces Limited has concluded with an Award dated July 8, 2025, passed by former Delhi High Court judge Justice Vinod Goel (Retd.). The dispute relates to USD 34.827 million that Vikas contributed as part of a consortium led by Eraaya for the acquisition of Ebix Inc. (USA), which was under Chapter 11 proceedings in a U.S. Bankruptcy Court. Eraaya had failed to repay Vikas's contribution within agreed timelines, citing delays in the release of USD 40 million from its own FCCB issue. The company has stated that the financial or operational impact of the award cannot be assessed in isolation, and the specific terms or monetary value of the award have not been disclosed in this filing.
This is a material development for shareholders because USD 34.827 million represents a sizeable exposure. The actual quantum and direction of the award are not yet public, so the stock may see volatility once the award details (especially any monetary recovery for Vikas) are made clear. Investors should watch for a follow-up disclosure specifying the award amount and any expected inflow from Eraaya.